260 related articles for article (PubMed ID: 33196900)
21. Pharmacological and clinical properties of calcimimetics: calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism.
Nagano N
Pharmacol Ther; 2006 Mar; 109(3):339-65. PubMed ID: 16102839
[TBL] [Abstract][Full Text] [Related]
22. Novel strategies in drug discovery of the calcium-sensing receptor based on biased signaling.
Thomsen AR; Smajilovic S; Bräuner-Osborne H
Curr Drug Targets; 2012 Sep; 13(10):1324-35. PubMed ID: 22702634
[TBL] [Abstract][Full Text] [Related]
23. Direct in vitro evidence of the suppressive effect of cinacalcet HCl on parathyroid hormone secretion in human parathyroid cells with pathologically reduced calcium-sensing receptor levels.
Kawata T; Imanishi Y; Kobayashi K; Onoda N; Okuno S; Takemoto Y; Komo T; Tahara H; Wada M; Nagano N; Ishimura E; Miki T; Ishikawa T; Inaba M; Nishizawa Y
J Bone Miner Metab; 2006; 24(4):300-6. PubMed ID: 16816924
[TBL] [Abstract][Full Text] [Related]
24. Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia.
Corbetta S; Mantovani G; Lania A; Borgato S; Vicentini L; Beretta E; Faglia G; Di Blasio AM; Spada A
Clin Endocrinol (Oxf); 2000 Mar; 52(3):339-48. PubMed ID: 10718832
[TBL] [Abstract][Full Text] [Related]
25. Pharmacology of AMG 416 (Velcalcetide), a novel peptide agonist of the calcium-sensing receptor, for the treatment of secondary hyperparathyroidism in hemodialysis patients.
Walter S; Baruch A; Dong J; Tomlinson JE; Alexander ST; Janes J; Hunter T; Yin Q; Maclean D; Bell G; Mendel DB; Johnson RM; Karim F
J Pharmacol Exp Ther; 2013 Aug; 346(2):229-40. PubMed ID: 23674604
[TBL] [Abstract][Full Text] [Related]
26. Regulator of G protein signaling 5 is highly expressed in parathyroid tumors and inhibits signaling by the calcium-sensing receptor.
Koh J; Dar M; Untch BR; Dixit D; Shi Y; Yang Z; Adam MA; Dressman H; Wang X; Gesty-Palmer D; Marks JR; Spurney R; Druey KM; Olson JA
Mol Endocrinol; 2011 May; 25(5):867-76. PubMed ID: 21393447
[TBL] [Abstract][Full Text] [Related]
27. [Calcimimetics, mechanisms of action and therapeutic applications].
Ureña P; Legoupil N; de Vernejoul MC
Presse Med; 2005 Sep; 34(15):1095-100. PubMed ID: 16334889
[TBL] [Abstract][Full Text] [Related]
28. Cinacalcet reduces the set point of the PTH-calcium curve.
Valle C; Rodriguez M; Santamaría R; Almaden Y; Rodriguez ME; Cañadillas S; Martin-Malo A; Aljama P
J Am Soc Nephrol; 2008 Dec; 19(12):2430-6. PubMed ID: 18632847
[TBL] [Abstract][Full Text] [Related]
29. [Long-term efficacy and safety of etelcalcetide in hemodialysis patients with severe secondary hyperparathyroidism].
Massimetti C; Tondo M; Feriozzi S
G Ital Nefrol; 2020 Oct; 37(5):. PubMed ID: 33026204
[No Abstract] [Full Text] [Related]
30. Improved Control of Secondary Hyperparathyroidism in Hemodialysis Patients Switching from Oral Cinacalcet to Intravenous Etelcalcetide, Especially in Nonadherent Patients.
Xipell M; Montagud-Marrahi E; Rubio MV; Ojeda R; Arias-Guillén M; Fontseré N; Rodas L; Vera M; Broseta JJ; Torregrosa V; Filella X; Maduell F
Blood Purif; 2019; 48(2):106-114. PubMed ID: 30699421
[TBL] [Abstract][Full Text] [Related]
31. Influence of dialysate Ca concentrations on the therapeutic effects of etelcalcetide with concomitant drugs in patients with secondary hyperparathyroidism.
Shigematsu T; Fukagawa M; Yokoyama K; Akiba T; Fujii A; Shinoda A; Akizawa T
Nephrology (Carlton); 2020 Aug; 25(8):634-643. PubMed ID: 31765028
[TBL] [Abstract][Full Text] [Related]
32. Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca(2+) set-point in patients with primary hyperparathyroidism.
Cetani F; Picone A; Cerrai P; Vignali E; Borsari S; Pardi E; Viacava P; Naccarato AG; Miccoli P; Kifor O; Brown EM; Pinchera A; Marcocci C
J Clin Endocrinol Metab; 2000 Dec; 85(12):4789-94. PubMed ID: 11134144
[TBL] [Abstract][Full Text] [Related]
33. An optogenetic approach for regulating human parathyroid hormone secretion.
Liu Y; Zhang L; Hu N; Shao J; Yang D; Ruan C; Huang S; Wang L; Lu WW; Zhang X; Yang F
Nat Commun; 2022 Feb; 13(1):771. PubMed ID: 35140213
[TBL] [Abstract][Full Text] [Related]
34. [The Discovery, Research and Development of Etelcalcetide Hydrochloride, the World 1st Intravenous Calcimimetics.].
Inoue A; Harada K
Clin Calcium; 2017; 27(4):537-545. PubMed ID: 28336830
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological regulation of parathyroid hormone secretion.
Nemeth EF
Curr Pharm Des; 2002; 8(23):2077-87. PubMed ID: 12171519
[TBL] [Abstract][Full Text] [Related]
36. Furosemide stimulation of parathormone in humans: role of the calcium-sensing receptor and the renin-angiotensin system.
Muller ME; Forni Ogna V; Maillard M; Stoudmann C; Zweiacker C; Anex C; Wuerzner G; Burnier M; Bonny O
Pflugers Arch; 2015 Dec; 467(12):2413-21. PubMed ID: 26089029
[TBL] [Abstract][Full Text] [Related]
37. Control of hyperparathyroidism with the intravenous calcimimetic etelcalcetide in dialysis patients adherent and non-adherent to oral calcimimetics.
Arenas MD; Rodelo-Haad C; de Mier MVP; Rodriguez M
Clin Kidney J; 2021 Mar; 14(3):840-846. PubMed ID: 33777366
[TBL] [Abstract][Full Text] [Related]
38. Calcium-mediated parathyroid hormone release changes in patients treated with the calcimimetic agent cinacalcet.
de Francisco AL; Izquierdo M; Cunningham J; Piñera C; Palomar R; Fresnedo GF; Amado JA; Unzueta MG; Arias M
Nephrol Dial Transplant; 2008 Sep; 23(9):2895-901. PubMed ID: 18424820
[TBL] [Abstract][Full Text] [Related]
39. Stimulating parathyroid cell proliferation and PTH release with phosphate in organ cultures obtained from patients with primary and secondary hyperparathyroidism for a prolonged period.
Nakajima K; Umino K; Azuma Y; Kosaka S; Takano K; Obara T; Sato K
J Bone Miner Metab; 2009; 27(2):224-33. PubMed ID: 19194773
[TBL] [Abstract][Full Text] [Related]
40. The full-length calcium-sensing receptor dampens the calcemic response to 1alpha,25(OH)2 vitamin D3 in vivo independently of parathyroid hormone.
Egbuna O; Quinn S; Kantham L; Butters R; Pang J; Pollak M; Goltzman D; Brown E
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F720-8. PubMed ID: 19474191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
